Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease

被引：7

作者：

Kremens, Daniel ^{[1
]}

Lew, Mark ^{[2
]}

Claassen, Daniel ^{[3
]}

Goodman, Brent P. ^{[4
]}

机构：

[1] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA

[2] Univ Southern Calif, Dept Neurol, Los Angeles, CA 90007 USA

[3] Vanderbilt Univ, Dept Neurol, 221 Kirkland Hall, Nashville, TN 37235 USA

[4] Mayo Clin Arizona, Dept Neurol, Scottsdale, AZ USA

来源：

CLINICAL AUTONOMIC RESEARCH | 2017年 / 27卷

关键词：

Fludrocortisone; Midodrine; Droxidopa; Neurogenic orthostatic hypotension; Parkinson's disease; SUPINE HYPERTENSION;

D O I：

10.1007/s10286-017-0434-6

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S29 / S31

页数：3

共 50 条

[21] Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus
Steven Vernino
Daniel Claassen
Clinical Autonomic Research, 2017, 27 : 33 - 34
[22] Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus
Vernino, Steven
Claassen, Daniel
CLINICAL AUTONOMIC RESEARCH, 2017, 27 : S33 - S34
[23] Prospects for Droxidopa in Neurogenic Orthostatic Hypotension
Ross, Amanda J.
Stewart, Julian M.
HYPERTENSION, 2015, 65 (01) : 34 - 35
[24] Droxidopa approved for neurogenic orthostatic hypotension
Traynor, Kate
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (07) : 520 - 520
[25] Droxidopa (Northera) for Neurogenic Orthostatic Hypotension
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1471): : 92 - 93
[26] Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa
Isaacson, Stuart H.
Skettini, Julia
VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 169 - 176
[27] Droxidopa and Midodrine Treatment Persistence in Patients With Orthostatic Hypotension
Hewitt, L. Arthur
Kymes, Steven
Jackson, Kenneth
Widolff, Michelle
Sullivan, Christine
Raj, Satish R.
NEUROLOGY, 2019, 92 (15)
[28] Droxidopa and Midodrine Treatment Persistence in Patients with Orthostatic Hypotension
Kymes, S.
Jackson, K.
Widolff, M.
Sullivan, C.
Hewitt, L.
Raj, S.
MOVEMENT DISORDERS, 2018, 33 : S364 - S365
[29] Droxidopa and Midodrine Treatment Persistence in Patients With Orthostatic Hypotension
Hewitt, L.
Kymes, S.
Jackson, K.
Widolff, M.
Sullivan, C.
Raj, S. R.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2019, 67 : S254 - S254
[30] Efficacy of midodrine for neurogenic orthostatic hypotension
Berlin, I
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (05): : 388 - 388

← 1 2 3 4 5 →